Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR
International Journal of Molecular Sciences · 30.07.2026 · 27 (15) · 6834
DOI: 10.3390/ijms27156834 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2026. Verfasst von Nunzia Santini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Urinary Bladder Neoplasms, Polymerase Chain Reaction, DNA, Satellite. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Naples Federico II, Croatian Science Foundation, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Bladder cancer (BC) is a common urological malignancy that lacks the non-invasive biomarkers that would make it suitable for early diagnosis. Human alpha-satellite DNA (hASAT) is a tandemly repeated centromeric/pericentromeric DNA family associated with chromosomal stability and cancer-related genomic instability. We quantified extracellular hASAT (ec-hASAT) in plasma circulating cell-free DNA by nanoplate-based digital PCR in a pilot cohort including 29 BC-negative samples, 10 patients with non-muscle-invasive BC (NMIBC), and 7 patients with muscle-invasive BC (MIBC). Plasma ec-hASAT copy number was higher in patients with BC than in the BC-negative group (Mann–Whitney U test, p = 6.61 × 10−7). BC-negative samples ranged from 225 to 11,864 copies/µL plasma, whereas BC samples ranged from 1138 to 16,097 copies/µL plasma. ROC analysis yielded an AUC of 0.944 for discriminating BC from BC-negative samples. At an exploratory threshold of 2000 copies/µL plasma, sensitivity was 94.1% (16/17; exact 95% CI, 71.3–99.9%) and specificity was 89.7% (26/29; exact 95% CI, 72.6–97.8%). These preliminary data support plasma ec-hASAT as a candidate minimally invasive biomarker for BC detection, including NMIBC, and justify validation in larger prospective cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
- Department of Molecular Biology, Ruder Boškovic Institute,10000 Zagreb, Croatia.
ORCID-Profile: Sven Ljubić, Damir Đermić, Đurđica Ugarković, Isidoro Feliciello
Förderung
- University of Naples Federico II
- Croatian Science Foundation
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Fund for Investments on Basic Research
Zitieren
APA
Santini, N., Procino, A., Ljubić, S., Đermić, D., Ugarković, Đ., & Feliciello, I. (2026). Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR. International Journal of Molecular Sciences, 27(15), 6834. https://doi.org/10.3390/ijms27156834
Vancouver
Santini N, Procino A, Ljubić S, Đermić D, Ugarković Đ, Feliciello I. Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR. International Journal of Molecular Sciences. 2026;27(15):6834. doi:10.3390/ijms27156834
BibTeX
@article{Santini2026,
author = {Santini, Nunzia and Procino, Alfredo and Ljubić, Sven and Đermić, Damir and Ugarković, Đurđica and Feliciello, Isidoro},
title = {Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6834},
doi = {10.3390/ijms27156834}
}
EUVIMED